Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Classifica tra le azioni #16725
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Prezzo delle azioni
$3.78
Ultima sincronizzazione: 2026-03-17
Capitalizzazione di mercato
$276.54M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
45.53%
Paese
CA
Scambia NervGen Pharma Corp. (NGEN)

Categoria

Storico del prezzo dell'azione per NervGen Pharma Corp. (NGEN)
Prezzo di chiusura più alto: $3.98 il 2026-03-01

Prezzo di chiusura più basso: $1.12 il 2019-03-01
Storico del prezzo dell'azione di NervGen Pharma Corp. dal 2019 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.21 -10.03%
AU
$755.10 7.83%
CH